Glassman Wealth Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-55
| Closed | -$1.72K | – | 217 |
|
2023
Q4 | $1.72K | Hold |
55
| – | – | ﹤0.01% | 1392 |
|
2023
Q3 | $1.15K | Hold |
55
| – | – | ﹤0.01% | 1512 |
|
2023
Q2 | $1.32K | Hold |
55
| – | – | ﹤0.01% | 1367 |
|
2023
Q1 | $1.04K | Hold |
55
| – | – | ﹤0.01% | 1420 |
|
2022
Q4 | $876 | Sell |
55
-25
| -31% | -$398 | ﹤0.01% | 1459 |
|
2022
Q3 | $1K | Sell |
80
-6
| -7% | -$75 | ﹤0.01% | 1303 |
|
2022
Q2 | $1K | Sell |
86
-135
| -61% | -$1.57K | ﹤0.01% | 1324 |
|
2022
Q1 | $5K | Buy |
221
+28
| +15% | +$633 | ﹤0.01% | 983 |
|
2021
Q4 | $5K | Buy |
193
+92
| +91% | +$2.38K | ﹤0.01% | 961 |
|
2021
Q3 | $2K | Buy |
101
+35
| +53% | +$693 | ﹤0.01% | 1124 |
|
2021
Q2 | $2K | Sell |
66
-258
| -80% | -$7.82K | ﹤0.01% | 1101 |
|
2021
Q1 | $8K | Buy |
324
+62
| +24% | +$1.53K | ﹤0.01% | 755 |
|
2020
Q4 | $14K | Buy |
262
+197
| +303% | +$10.5K | ﹤0.01% | 618 |
|
2020
Q3 | $3K | Hold |
65
| – | – | ﹤0.01% | 873 |
|
2020
Q2 | $3K | Hold |
65
| – | – | ﹤0.01% | 718 |
|
2020
Q1 | $3K | Buy |
65
+6
| +10% | +$277 | ﹤0.01% | 583 |
|
2019
Q4 | $3K | Buy |
59
+4
| +7% | +$203 | ﹤0.01% | 648 |
|
2019
Q3 | $2K | Sell |
55
-8
| -13% | -$291 | ﹤0.01% | 660 |
|
2019
Q2 | $2K | Sell |
63
-14,992
| -100% | -$476K | ﹤0.01% | 684 |
|
2019
Q1 | $404K | Buy |
15,055
+55
| +0.4% | +$1.48K | 0.18% | 69 |
|
2018
Q4 | $243K | Hold |
15,000
| – | – | 0.13% | 87 |
|
2018
Q3 | $311K | Hold |
15,000
| – | – | 0.14% | 81 |
|
2018
Q2 | $229K | Buy |
15,000
+14,989
| +136,264% | +$229K | 0.11% | 82 |
|
2018
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 717 |
|
2017
Q4 | – | Sell |
-140
| Closed | -$5K | – | 650 |
|
2017
Q3 | $5K | Hold |
140
| – | – | ﹤0.01% | 348 |
|
2017
Q2 | $4K | Hold |
140
| – | – | ﹤0.01% | 363 |
|
2017
Q1 | $5K | Hold |
140
| – | – | ﹤0.01% | 397 |
|
2016
Q4 | $4K | Hold |
140
| – | – | ﹤0.01% | 440 |
|
2016
Q3 | $4K | Buy |
+140
| New | +$4K | ﹤0.01% | 370 |
|